Zeitlinger, M A <br/><br/>
Effective treatment of a peripheral T-cell lymphoma/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab.  [electronic resource] 

 -  Leukemia & lymphoma  May 2005 
 - 771-4 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.1080/10428190400028959  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alemtuzumab<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--therapeutic use<br/>Antigens, CD--immunology<br/>Antigens, Neoplasm--immunology<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>CD52 Antigen<br/>Glycoproteins--immunology<br/>Humans<br/>Immunotherapy--methods<br/>Lymphoma, T-Cell, Peripheral--drug therapy<br/>Male